Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2007136227', 'doi': 'https://doi.org/10.1586/era.09.153', 'title': 'Bevacizumab and breast cancer: current therapeutic progress and future perspectives', 'display_name': 'Bevacizumab and breast cancer: current therapeutic progress and future perspectives', 'publication_year': 2009, 'publication_date': '2009-12-01', 'ids': {'openalex': 'https://openalex.org/W2007136227', 'doi': 'https://doi.org/10.1586/era.09.153', 'mag': '2007136227', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19954282', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/2819039'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/era.09.153', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://europepmc.org/articles/pmc2819039?pdf=render', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5103006156', 'display_name': 'Sherry X. Yang', 'orcid': 'https://orcid.org/0000-0002-3180-9190'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Sherry X Yang', 'raw_affiliation_strings': ['National Clinical Target Validation Laboratory, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Building, 37/Room 1048, 37 Convent Drive, Bethesda, MD, 20892 USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'National Clinical Target Validation Laboratory, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Building, 37/Room 1048, 37 Convent Drive, Bethesda, MD, 20892 USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210140884']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5103006156'], 'corresponding_institution_ids': ['https://openalex.org/I4210140884'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.522, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 20, 'citation_normalized_percentile': {'value': 0.224917, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '9', 'issue': '12', 'first_page': '1715', 'last_page': '1725'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10422', 'display_name': 'Molecular Mechanisms of Angiogenesis and Vascular Function', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Advancements in Colorectal Cancer Research', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.7525213}, {'id': 'https://openalex.org/keywords/bevacizumab', 'display_name': 'Bevacizumab', 'score': 0.55927}, {'id': 'https://openalex.org/keywords/metastatic-breast-cancer', 'display_name': 'Metastatic Breast Cancer', 'score': 0.514583}], 'concepts': [{'id': 'https://openalex.org/C2777802072', 'wikidata': 'https://www.wikidata.org/wiki/Q413299', 'display_name': 'Bevacizumab', 'level': 3, 'score': 0.9727341}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9395405}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.7543292}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.7525213}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.6574671}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.60390604}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.6005663}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.5637291}, {'id': 'https://openalex.org/C2777863537', 'wikidata': 'https://www.wikidata.org/wiki/Q357896', 'display_name': 'Adjuvant', 'level': 2, 'score': 0.42201954}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.40467262}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.12590718}], 'mesh': [{'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068258', 'descriptor_name': 'Bevacizumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000098', 'qualifier_name': 'blood supply', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009389', 'descriptor_name': 'Neovascularization, Pathologic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009389', 'descriptor_name': 'Neovascularization, Pathologic', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D042461', 'descriptor_name': 'Vascular Endothelial Growth Factor A', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D042461', 'descriptor_name': 'Vascular Endothelial Growth Factor A', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/era.09.153', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2819039', 'pdf_url': 'https://europepmc.org/articles/pmc2819039?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819039', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19954282', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2819039', 'pdf_url': 'https://europepmc.org/articles/pmc2819039?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.83, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 58, 'referenced_works': ['https://openalex.org/W1539571840', 'https://openalex.org/W1665704747', 'https://openalex.org/W1925212740', 'https://openalex.org/W1975341588', 'https://openalex.org/W1978139448', 'https://openalex.org/W1987122320', 'https://openalex.org/W1993016882', 'https://openalex.org/W2000292756', 'https://openalex.org/W2013038209', 'https://openalex.org/W2013538303', 'https://openalex.org/W2013965516', 'https://openalex.org/W2020724013', 'https://openalex.org/W2022233074', 'https://openalex.org/W2030437674', 'https://openalex.org/W2030722611', 'https://openalex.org/W2036022311', 'https://openalex.org/W2036751011', 'https://openalex.org/W2040089666', 'https://openalex.org/W2049051984', 'https://openalex.org/W2054728198', 'https://openalex.org/W2056146626', 'https://openalex.org/W2061094294', 'https://openalex.org/W2062594120', 'https://openalex.org/W2063766394', 'https://openalex.org/W2068014745', 'https://openalex.org/W2070264012', 'https://openalex.org/W2084506573', 'https://openalex.org/W2090310262', 'https://openalex.org/W2098073308', 'https://openalex.org/W2106465230', 'https://openalex.org/W2109134893', 'https://openalex.org/W2113361623', 'https://openalex.org/W2114148421', 'https://openalex.org/W2114159573', 'https://openalex.org/W2114426106', 'https://openalex.org/W2117188579', 'https://openalex.org/W2122298066', 'https://openalex.org/W2123175319', 'https://openalex.org/W2125447919', 'https://openalex.org/W2125651014', 'https://openalex.org/W2126275851', 'https://openalex.org/W2129643153', 'https://openalex.org/W2130334661', 'https://openalex.org/W2131705241', 'https://openalex.org/W2145835533', 'https://openalex.org/W2154200023', 'https://openalex.org/W2154502317', 'https://openalex.org/W2157769714', 'https://openalex.org/W2162352067', 'https://openalex.org/W2163003060', 'https://openalex.org/W2170367762', 'https://openalex.org/W2247075085', 'https://openalex.org/W2270510191', 'https://openalex.org/W2317494592', 'https://openalex.org/W2318749957', 'https://openalex.org/W2338264812', 'https://openalex.org/W2406954741', 'https://openalex.org/W3081058368'], 'related_works': ['https://openalex.org/W4311628015', 'https://openalex.org/W3191427281', 'https://openalex.org/W3142026086', 'https://openalex.org/W2557455638', 'https://openalex.org/W2146312028', 'https://openalex.org/W2037317309', 'https://openalex.org/W2028827184', 'https://openalex.org/W2009268313', 'https://openalex.org/W1992038096', 'https://openalex.org/W1753883657'], 'abstract_inverted_index': {'Bevacizumab': [0, 28, 72], 'is': [1, 15, 59, 73], 'a': [2], 'humanized': [3], 'monoclonal': [4], 'antibody': [5], 'to': [6, 13], 'VEGF,': [7], 'and': [8, 39, 58, 69, 76, 84, 91, 99], 'the': [9, 18, 23, 41, 111], 'incorporation': [10], 'of': [11, 17, 25, 87, 105, 113], 'bevacizumab': [12, 88], 'chemotherapy': [14, 32, 34], 'one': [16], 'rapidly': [19], 'evolving': [20], 'areas': [21], 'in': [22, 29, 44, 67], 'treatment': [24], 'breast': [26, 52, 65], 'cancer.': [27, 53], 'combination': [30], 'with': [31, 121], 'versus': [33], 'alone': [35], 'improves': [36], 'progression-free': [37], 'survival': [38], 'increases': [40], 'response': [42, 90], 'rate': [43], 'first-line': [45], 'therapy': [46, 120], 'for': [47, 63], 'locally': [48], 'recurrent': [49], 'or': [50], 'metastatic': [51], 'This': [54], 'approach': [55], 'has': [56, 77], 'been': [57], 'still': [60], 'being': [61], 'evaluated': [62], 'early': [64], 'cancer': [66], 'neoadjuvant': [68], 'adjuvant': [70], 'settings.': [71], 'well': [74], 'tolerated': [75], 'an': [78], 'established': [79], 'tolerability': [80], 'profile.': [81], 'Both': [82], 'tumor-': [83], 'host-related': [85], 'biomarkers': [86, 104], 'activity,': [89], 'benefit': [92, 106, 117], 'are': [93], 'emerging': [94], 'from': [95, 118], 'Phase': [96], 'I,': [97], 'II': [98], 'III': [100], 'clinical': [101], 'trials.': [102], 'The': [103], 'will': [107], 'ultimately': [108], 'help': [109], 'identify': [110], 'subgroups': [112], 'patients': [114], 'who': [115], 'specifically': [116], 'anti-VEGF': [119], 'bevacizumab.': [122]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2007136227', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 4}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-08-31T16:40:02.181973', 'created_date': '2016-06-24'}